The Cooperative Induction of Hypoxia-Inducible Factor-1α and STAT3 during Hypoxia Induced an Impairment of Tumor Susceptibility to CTL-Mediated Cell Lysis

被引:147
作者
Noman, Muhammad Zaeem
Buart, Stephanie
Van Pelt, Jos [2 ]
Richon, Catherine
Hasmim, Meriem
Leleu, Nathalie
Suchorska, Wictoria Maria
Jalil, Abdelali
Lecluse, Yann [3 ]
El Hage, Faten
Giuliani, Massimo [4 ]
Pichon, Christophe
Azzarone, Bruno [4 ]
Mazure, Nathalie [5 ]
Romero, Pedro [6 ]
Mami-Chouaib, Fathia
Chouaib, Salem [1 ]
机构
[1] Inst Gustave Roussy, INSERM, U753, F-94805 Villejuif, France
[2] Univ Hosp Gasthuisberg, Dept Hepatol, B-3000 Louvain, Belgium
[3] Inst Gustave Roussy PR2, Villejuif, France
[4] Univ Paris 11, Hop Paul Brousse, INSERM, UMR 542, Villejuif, France
[5] CNRS, Inst Signalling Dev Biol & Canc Res, UMR 6543, F-06034 Nice, France
[6] Ludwig Inst Canc Res, Div Clin Oncoimmunol, Lausanne, Switzerland
关键词
CYTOTOXIC T-LYMPHOCYTE; HUMAN LUNG-CARCINOMA; SIGNAL TRANSDUCERS; VEGF EXPRESSION; CANCER-THERAPY; FACTOR-ALPHA; HIF-1; IMMUNOTHERAPY; APOPTOSIS; TARGET;
D O I
10.4049/jimmunol.0800854
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hypoxia is an essential component of tumor microenvironment. In this study, we investigated the influence of hypoxia (1% PO2) on CTL-mediated tumor cell lysis. We demonstrate that exposure of target tumor cells to hypoxia has an inhibitory effect on the CTL clone (Heu171)-induced autologous target cell lysis. Such inhibition correlates with hypoxia-inducible factor-1 alpha (HIF-1 alpha) induction but is not associated with an alteration of CTL reactivity as revealed by granzyme B polarization or morphological change. Western blot analysis indicates that although hypoxia had no effect on p53 accumulation, it induced the phosphorylation of STAT3 in tumor cells by a mechanism at least in part involving vascular endothelial growth factor secretion. We additionally show that a simultaneous nuclear translocation of HIF-1 alpha and phospho-STAT3 was observed. Interestingly, gene silencing of STAT3 by small interfering RNA resulted in HIF-1 alpha inhibition and a significant restoration of target cell susceptibility to CTL-induced killing under hypoxic conditions by a mechanism involving at least in part down-regulation of AKT phosphorylation. Moreover, knockdown of HIF-1 alpha resulted in the restoration of target cell lysis under hypoxic conditions. This was further supported by DNA microarray analysis where STAT3 inhibition resulted in a partly reversal of the hypoxia-induced gene expression profile. The present study demonstrates that the concomitant hypoxic induction of phopho-STAT3 and HIF-1 alpha are functionally linked to the alteration of non-small cell lung carcinoma target susceptibility to CTL-mediated killing. Considering the eminent functions of STAT3 and HIF-1 alpha in the tumor microenvironment, their targeting may represent novel strategies for immunotherapeutic intervention. The Journal of Immunology, 2009, 182: 3510-3521.
引用
收藏
页码:3510 / 3521
页数:12
相关论文
共 56 条
  • [1] Identification of target actin content and polymerization status as a mechanism of tumor resistance after cytolytic T lymphocyte pressure
    Abouzahr, S
    Bismuth, G
    Gaudin, C
    Caroll, O
    Van Endert, P
    Jalil, A
    Dausset, J
    Vergnon, I
    Richon, C
    Kauffmann, A
    Galon, J
    Raposo, G
    Mami-Chouaib, F
    Chouaib, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (05) : 1428 - 1433
  • [2] Aebersold DM, 2001, CANCER RES, V61, P2911
  • [3] The tumour microenvironment as a target for chemoprevention
    Albini, Adriana
    Sporn, Michael B.
    [J]. NATURE REVIEWS CANCER, 2007, 7 (02) : 139 - 147
  • [4] Asselin-Paturel C, 2001, CANCER-AM CANCER SOC, V91, P113, DOI 10.1002/1097-0142(20010101)91:1<113::AID-CNCR15>3.0.CO
  • [5] 2-7
  • [6] Blaskovich MA, 2003, CANCER RES, V63, P1270
  • [7] Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis
    Bowman, T
    Broome, MA
    Sinibaldi, D
    Wharton, W
    Pledger, WJ
    Sedivy, JM
    Irby, R
    Yeatman, T
    Courtneidge, SA
    Jove, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (13) : 7319 - 7324
  • [8] Stat3 as an oncogene
    Bromberg, JF
    Wrzeszczynska, MH
    Devgan, G
    Zhao, YX
    Pestell, RG
    Albanese, C
    Darnell, JE
    [J]. CELL, 1999, 98 (03) : 295 - 303
  • [9] Catlett-Falcone Robyn, 1999, Current Opinion in Oncology, V11, P490, DOI 10.1097/00001622-199911000-00010
  • [10] Integrating the quality of the cytotoxic response and tumor susceptibility into the design of protective vaccines in tumor immunotherapy
    Chouaib, S
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (05) : 595 - 597